M. tuberculosis in Lymph Node Biopsy Paraffin-Embedded Sections by Eshete, Abdurehman et al.
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2011, Article ID 127817, 5 pages
doi:10.1155/2011/127817
Clinical Study
M.tuberculosis in Lymph NodeBiopsy
Parafﬁn-EmbeddedSections
AbdurehmanEshete,AhmedZeyinudin,Solomon Ali,
Solomon Abera, andMona Mohammed
Department of Medical Laboratory Sciences and Pathology, College of Public Health and Medical Sciences,
Jimma University, 409 Jimma, Ethiopia
Correspondence should be addressed to Abdurehman Eshete, abdurehman.eshete@ju.edu.et
Received 29 June 2011; Revised 1 October 2011; Accepted 17 October 2011
Academic Editor: S. G. Franzblau
Copyright © 2011 Abdurehman Eshete et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. Tuberculosis lymphadenitis is one of the most common forms of all extrapulmonary tuberculosis. Objective.T o
evaluate the magnitude of M. tuberculosis from lymph node biopsy paraﬃn-embedded sections among suspected patients visiting
the Jimma University Specialized Hospital. Method. A cross-sectional study design of histological examination among lymph node
biopsy paraﬃn-embedded sections by Ziehl-Neelsen and hematoxylin/eosin staining technique was conducted from December,
2009, to October, 2010, at the Department of Medical Laboratory Science and Pathology. Result. Histopathological examination
of the specimens by hematoxylin and eosin staining technique revealed the presence of granulomas. But for the caseation and
necrosis they were present in 85% cases of nodal tissue biopsies. From those, 56.7% were from females. The presence of acid-fast
bacilli was microscopically conﬁrmed by ZN staining in 37 (61.7%) of the nodal tissue biopsies. Conclusion and Recommendation.
Tuberculosis lymphadenitis is signiﬁcantly more common in females. Hence, attention should be given for control and prevention
of extrapulmonary tuberculosis.
1.Introduction
Tuberculosis (TB) remains a major global public health
problem. It is estimated that about one-third of the world’s
population is infected with Mycobacterium tuberculosis.
There were an estimated 8 million new cases of TB, resulting
in 1.9 million deaths, with the greatest burden of disease in
developing nations [1–3].
The genus Mycobacterium consists of nonmotile, non-
spore-forming aerobic acid-fast bacilli. The cell wall is
lipophilic and resistant to many disinfectants as well as to
common laboratory stains. Currently, more than 70 species
of Mycobacterium have been identiﬁed, many of which are
associated with human diseases [4].
Ag r o u po fMycobacterium species called M. tubercu-
losis complex, comprise M. tuberculosis, M. bovis,a n dM.
africanum, is of at most clinical importance since it causes
tuberculosis in humans worldwide. Mycobacteria species
other than those of the tuberculosis complex, also called
nonmycobacteria, are widely distributed in the environment
and may colonize and occasionally cause infections in hu-
mans [5].
The incidence of tuberculosis has stabilized or declined
in most of the world WHO regions. On the other hand,
it is increasing in Africa, Southeast Asia, and the Eastern
Mediterranean. This is associated with high prevalence of
the pandemic human immunodeﬁciency virus (HIV) in
these regions. More than 4,000 people died daily in both pul-
monary and extrapulmonary tuberculosis-related illnesses
[6].
Tuberculosis infection can be of pulmonary or extra-
pulmonary type. After primary infection, TB may reactivate
at anytime and anywhere in the body. Recent studies have
suggested that the sites of extrapulmonary tuberculosis are
lymph nodes in the neck, the bones, the serous membranes,
and the cervical region. Tuberculosis of the lymphatic system2 Tuberculosis Research and Treatment
is one of the most common of all extrapulmonary tubercu-
losis [1, 7, 8].
Lymph nodes involvement is the most common form of
extrapulmonary tuberculosis. The synergy between tubercu-
losis and HIV infection and other immune-compromising
conditions have resulted in an increase in the incidence
of tuberculosis lymphadenitis and have further complicated
tuberculosis control. HIV-related extrapulmonary tubercu-
losis is a World Health Organization (WHO) clinical stage
four diagnosis, and patients with HIV-related extrapul-
monary tuberculosis often have disseminated disease and are
at high risk of rapid clinical deterioration and death [9–11].
Tuberculosis lymphadenitis occurs relatively early after
primary infection with M. tuberculosis and often aﬀects
young people in countries with a high prevalence of tuber-
culosis. In children, the most serious forms are disseminated
tuberculosis and tuberculosis meningitis. Tuberculosis lym-
phadenitis is the most common form, accounting for up to
50 percent of extrapulmonary cases in children [12, 13].
The extrapulmonary variety is now beginning to emerge
from the shadows of pulmonary tuberculosis. In countries
with good surveillance data like USA where the rate of
pulmonary tuberculosis has declined to its lowest levels ever
in 2001, statistics indicate a relative increase of extrapul-
monary cases from 16% in 1992 to 20% in 2000. In USA the
prevalence of extrapulmonary among immune competent
persons was 15–30% [14].
Extrapulmonary tuberculosis (EPTB) has existed as a
disease entity for centuries. It is a milder form of disease in
terms of infectivity as compared to pulmonary tuberculosis.
In India, EPTB comprises 20% of all TB cases. Its prevalence
in the country varies between 8.3 and 13.1% in diﬀerent
districts in 2002. In the year 2006, 183,180 EPTB cases were
registered in comparison to 555,660 smear pulmonary TB
cases giving a ratio of 1:0.3. Cure of infectious cases is
likely to have resulted in a relative rise of annual EPTB case
detection. Prevalence of EPTB has also been found to be
higher in paediatric cases [7, 15].
Extrapulmonary tuberculosis can occur alone or in com-
bination with the pulmonary variety. It is usually conﬁned to
a single site, but disseminated form may also occur. Many
of the aﬀected sites may require an invasive procedure to
get a biological sample to reach a diagnosis. Extrapulmonary
tuberculosis remains a diagnosis that is often diﬃcult to
establish immediately and available [16].
2. Method and Materials
First ethical clearance was obtained from the Jimma Uni-
versity ethical review board. The purpose of the study was
clearly explained for the study subjects, and written consent
wasobtainedfromeachstudyparticipants.Conﬁdentialityof
the result was kept by coding patient information and spec-
imen.
A cross-sectional study design was conducted on par-
aﬃn-embedded lymph node biopsy sections in Jimma Uni-
versity Specialized Hospital (JUSH), the Jimma, Ethiopia.
This study was done to determine the magnitude of
M. tuberculosis among patients suspected for Tuberculosis
lymphadenitis from December, 2009, to October, 2010.
Jimma University is found in Jimma zone, Jimma town
Woreda; the town is located 335km southwest of the capital
Addis Ababa. The town has a characteristic of tropical high-
land climate condition, heavy rain fall, warm temperature,
and long wet period [17].
All suspected patients with clinical presentation of uni-
lateral or bilateral, solitary or matted, painless mass in the
regional lymphatic area were included.
S o c i o d e m o g r a p h i ca n ds o u r c eo fs p e c i m e nd a t aw e r e
collected by predesigned questionnaire. The result was noted
on data collection format.
The fresh specimen was immersed in 10% formalin be-
fore subjecting the specimen to tissue-processing machine
(Leica TP1020). The ﬁxed specimen is then placed in
a machine that automatically goes through an elaborate
overnight cycle that removes all the water from the specimen
a n dr e p l a c e si tw i t hp a r a ﬃnw a x .
The next morning the paraﬃn-impregnated specimen
w a se m b e d d e di nal a r g e rb l o c ko fm o l t e np a r a ﬃn. Then
the block was trimmed and sectioned by microtome (Leica
RM2245). Finally, the delicate sections were ﬂoated out on
a water bath and picked up on a glass slide. The paraﬃn
was dissolved from the tissue on the slide by incubator and
stained by H/E and AFB stain separately.
3. Result
In this study a total of 60 study participants were included.
Of these 20 (33.3%) were males and the rest 40 (66.7%) were
females. The female-to-male ratio of study subjects was 2:1.
Regarding study participants, age distribution, 14
(23.3%)ofthestudysubjectswerebelow15years,34(56.7%)
within 15–45 years, and 12 (20%) above 45 years (Table 1).
Concerning the site from which the lymph node biopsy
is collected, 30 (50%) were collected from cervical, 18 (30%)
axillary, 10 (16.7%) mesenteric, and 2 (3.3%) inguinal site.
This showed that cervical lymph nodes are more involved
than others (Table 1).
Histopathology examination of the specimens revealed
the presence of granulomas in the lymph node tissues with
marked epitheloid cell changes as well as giant cells for-
mation,but,forthecaseationandnecrosis,theywerepresent
in 51 (85%) cases of nodal biopsies. From those majority, 34
(56.7%) were seen from female samples (Figure 1).
Histopathologically, the granulomas of tuberculosis tend
to contain caseation necrosis, but nonnecrotizing granu-
lomas were also been present. The caseating necrosis was
present in 51 (85%) of the nodal specimens. Necrotizing
granulomas are characteristic of infectious diseases such as
t u b e r c u l o s i sa n df u n g a li n f e c t i o n sa sw e l la sr h e u m a t o i d
nodules, Wegener’s granulomatosis, necrobiotic postsurgical
granulomas, and others.
As it is seen from Figure 2, the presence of visible
cheese-like appearance might be associated with necrotizing
granulomas as well as necrotic neoplasms. However, non-
necrotizing granulomas may occur along with necrotizing
granulomas in infectious diseases such as tuberculosis.Tuberculosis Research and Treatment 3
Table 1: Sex distribution of Ziehl-Neelsen-stained paraﬃn-em-
bedded lymph node biopsy sections by anatomical site and age,
Jimma University specialized Hospital, the Jimma, Ethiopia, 2010.
Anatomical sites Male n (%) Female n (%) Total n (%)
Cervical
Positive
Negative
Total
3 (10)
3 (10)
6 (20)
19 (63.3)
5 (16.7)
24 (80)
22 (73.3)
8 (26.7)
30 (100)
Axillary
Positive
Negative
Total
3 (16.7)
4 (22.2)
7 (38.9)
9 (50)
2 (11.1)
11 (61.1)
12 (66.7)
6 (33.3)
18 (100)
Mesenteric
Positive
Negative
Total
1 (10)
5 (50)
6 (60)
2 (20)
2 (20)
4 (40)
3 (30)
7 (70)
10 (100)
Inguinal
Positive
Negative
Total
0
1
1
0
1
1
0
2
2
Age distribution
<15 years
Positive
Negative
Total
1 (7.1)
1 (7.1)
2 (14.2)
6 (42.9)
6 (42.9)
12 (85.8)
7 (50)
7 (50)
14 (100)
15–45 years
Positive
Negative
Total
6 (17.6)
4 (11.8)
10 (29.4)
24 (70.5)
0
24 (70.5)
30 (88.1)
4 (11.8)
34 (100)
>45 years
Positive
Negative
Total
0
8 (66.7)
8 (33.3)
0
4 (33.3)
4 (33.3)
0
12 (100)
12 (100)
Figure 1: Lymph node biopsy showing epitheloid cell changes in
H/E stain by 400x.
From the total sixty specimens examined by ZN staining
technique, AFB was microscopically recognized and con-
ﬁrmed in 37 (61.7%) of the nodal tissue biopsies; the bacilli
were scanty in the tissues and were seen in the granulomas
associated mainly within the epitheloid cells as well as in the
necrotic caseation areas. The AFB seen was fragmented or
beaded rods present inside the cells or outside near the cell
(macrophages) (Figure 3).
The prevalence of M. tuberculosis among the study sub-
jects was 61.7%. The highest percentage of AFB was seen in
females (81%), and the rest 19% was in males.
Figure 2: Lymph node biopsy showing giant cells and caseation in
H/E stain by 400x.
Figure3:Fragmentedorbeadedrods(AFB)seeninsideandoutside
macrophages in ZN staining by 400x.
4. Discussion
The main limitations of this study is unable to use more sen-
sitive advanced molecular techniques like PCR and culturing
method for the detection of M. tuberculosis. This is due to
facility and logistics constraints. Even if we used less sensitive
detection technique, the magnitude of M. tuberculosis from
lymph node paraﬃn sections was still high on patients
clinically suspected for tuberculosis lymphadenitis at the
Jimma University Specialized Hospital. Apart from this, it
was impossible to access the HIV status and CD4 count of
the study participants because of the high conﬁdentiality of
HIV screening result and expensiveness of CD4 count.
In this cross-sectional study sixty study subjects were in-
volved, and lymph node specimens were collected from all
individuals from cervical, axillary, mesenteric, and inguinal.
All the specimens were stained using both H/E and ZN
staining techniques.
After the specimens are stained by H/E staining method,
caseating necrosis was observed during microscopic exam-
ination in 51 (85%) of the specimens. The presence of
caseating necrosis might be due to M. tuberculosis or other
microorganisms.
The presences of M. tuberculosis in 37 lymph node sam-
plesweredemonstratedusingZNstainingtechnique,andthe
sources of the lymph node samples were in diﬀerent sites.
As ZN method is relatively conﬁrmatory method than H/E
for M. tuberculosis from lymph node specimens, the overall
prevalence of M. tuberculosis using ZN staining method was
61.7%.
Cytological diagnosis conducted in enlarged lymph
nodes lesions in Russia from a total of 114 patients, 18.5%
werepositivefortuberculosis,andTBLNisafrequentﬁnding4 Tuberculosis Research and Treatment
Table 2: Summery of M. tuberculosis prevalence from paraﬃn-
embedded biopsy sections in diﬀerent countries.
Country (year) No. of specimens AFB result
Russia (2002) [18] 114 18.5%
Germany (1999) [19] 16 36%
Israel (2000) [20] 21 85.7%
University of Malaya (1994) [21] 59 49%
Ethiopia (Butajira) (2002) [22] 147 72%
Jimma (this study) 60 61.7%
among adult women in two-third of all tuberculosis cases
and in children it was reported to be (3.7%) (Table 2)[ 19].
On the other hand, in our study from a total of 60
analyzedlymphnodesamples,40(66.7%)werefromfemales
and 20 (33.3%) were from male patients; from these 37
(61.7%) were positive for AFB by ZN staining technique.
From the total examined lymph node tissue sample, most
lymph node samples were taken from females and 30 (81%)
of female lymph node revealed the presence of AFB. On the
other hand, only 7 (18.9%) of males revealed the presence
of AFB. This ﬁnding is quite diﬀerent from the gender
breakdown seen in pulmonary tuberculosis. For instance a
study done in one district of Jimma zone (our catchment
area) indicated that majority (65.6%) of the smear positive
pulmonary tuberculosis participants were males [23]. From
the total positive lymph nodes seen, 30 (81%) were between
the age of 15 and 45 years, 7 (18.9%) were under 15 years,
and in the age of above 45 years there were no patients with
AFB.
A study conducted on a total of 16 patients treated at
medical outpatient clinic because of TBLN in Germany;
10% patients has showed cervical lymph nodes, and other
localization were supraclavicular, inguinal, and axillary of
which 36% showed AFB (Table 2)[ 19]. Whereas this study
revealedthat30(50%)cervical,18(30%)axillary,10(16.7%)
mesenteric, and 2 (3.3%) inguinal lymph node samples, and
from these 37 (61.7%) were positive for AFB by ZN staining.
Another study conducted in Israel for diagnosis and
treatment of cervical TBLN, from a total of 21 patients, 18
(85.7%)ofthemwerepositiveforAFB(Table 2)[20]whereas
in our study, from a total of 60 subjects, 37 of them were
positive for AFB. The diﬀerence between the magnitudes of
the two studies might be due to variation in the type of
specimen collected.
According to a study done on histopathology of lymph
nodal tuberculosis at the Department of Pathology, Univer-
sityofMalaya,59casesoftuberculosiscervicallymphadenitis
were analyzed by ZN stain and 29 (49.2%) case showed AFB
(Table 2)[ 21].
In a study conducted at North Germany to assess TBLN,
cervical lymph node was the most frequently involved
(63.3%) followed by mediastinal lymph node (26.7%) and
the axillary lymph nodes (8.3%) [24] whereas in this study
the most frequently involved lymph node site was cervical
(64.9%), axillary (27%), and mediastinal (8%).
A study conducted in the identiﬁcation of the causative
agent of TBLN in rural health center in South Ethiopia
revealed the presence of tuberculosis in 75% of patients,
whereas in our case the prevalence rate was 61.7%. The gap
for the variation in the prevalence might be due to the type
of methods used [25].
A study conducted in Butajira, rural Ethiopia, to diag-
nose TBLN, among a total of 147 clinical suspected patients
72%ofthem,wereconﬁrmedasTBLN(Table 2)[22].Onthe
other hand, our study has revealed 61.7% and these ﬁnding
are comparable with each other.
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